RICK

RICK is a cash machine trading like a troubled one. FY2025 operating cash flow was $49.4M against just $14.5M of capex, leaving roughly $34.9M of free cash flow — about 16% of the $212M market cap, or ~6x FCF. Reported EPS of $1.23 (P/E 22.3) understates that generation because of $15.1M in D&A and prior impairment noise; the operating line tells the cleaner story, with operating income up 61% to $30.3M and a 10.8% operating margin. Management is funneling that cash into per-share value: shares outstanding fell 13.4% to 7.71M, with $11.9M of buybacks and a small dividend. In a low-float name, that compounding is the core of the bull case, and at 0.8x sales with net income recovering off a depressed FY2024 ($3.0M, impairment-hit), you are not paying up for it.

The warts are real, though, which is why this is a conviction-3 buy rather than a table-pounder. The top line is going the wrong way — revenue fell 5.5% to $279M, below the FY2023–24 peak (~$294–296M) — so the recovery in profit is margin/mix-driven, not demand-driven. ROE is a thin 4.1% and net margin only 3.9%. The balance sheet carries $236M of total debt against $33.7M cash and $261M equity (liabilities/equity 1.29x), and current liabilities ($63.0M) exceed current assets ($50.9M); the 10-K explicitly flags covenant-compliance risk where a breach could make debt 'immediately due and payable.'